Phase I/II Trial of GN-BVC, a Gemcitabine and Vinorelbine-Containing Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in Recurrent and Refractory Hodgkin Lymphoma-Reference-Cited by-同舟云学术

Phase I/II Trial of GN-BVC, a Gemcitabine and Vinorelbine-Containing Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in Recurrent and Refractory Hodgkin Lymphoma

Published:2010-08 Issue:8 Volume:16 Page:1145-1154
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Arai Sally,Letsinger Renee,Wong Ruby M.,Johnston Laura J.,Laport Ginna G.,Lowsky Robert,Miklos David B.,Shizuru Judith A.,Weng Wen-Kai,Lavori Philip W.,Blume Karl G.,Negrin Robert S.,Horning Sandra J.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference61 articles.

1. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomized trial;Linch;Lancet,1993

2. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomized trial;Schmitz;Lancet,2002

3. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP);Velasquez;Blood,1988

4. Time-intensified dexamethasone/cisplatin/cytarabine: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin's disease;Josting;Ann Oncol,2002

5. A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model;Moskowitz;Blood,2001

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents;Blood;2023-03-01

2. Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma;Blood Advances;2021-12-08

3. FDG PET for Assessment of Autologous Stem Cell Transplantation;Seminars in Nuclear Medicine;2021-07

4. Relapsed and Refractory Hodgkin Lymphoma;Hodgkin Lymphoma;2020

5. Diagnosis and Treatment of Hodgkin Lymphoma;Neoplastic Diseases of the Blood;2017-09-23